Milan, June 15, 2010 – Sorin S.p.A. announces that the Board of Directors, meeting today in Milan, co-opted Massimo Tononi as Member of the Board of Directors, and of the Executive Committee of the Board of Directors, in replacement of Giovanni Gorno Tempini, whose resignation had been previously communicated.The Curriculum Vitae of Massimo Tononi is available on the company’s Internet site at the address www.sorin.com.

About the Sorin Group
The Sorin Group (www.sorin.com), is a global medical device company and a leader in the treatment of cardiovascular diseases. The Company develops, manufactures and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders. With 3,600 employees worldwide, the Group focuses on three major therapeutic areas that include: cardiopulmonary bypass (extracorporeal circulation and autotransfusion systems), cardiac rhythm management, and heart valve repair and replacement. Every year, over 1 million patients are treated with the devices of Sorin Group in more than 80 countries.

For more information contact:
Martine Konorski
Director, Corporate Communications
Sorin Group
Tel: +33 (0)1 46 01 33 78
Mobile: +33 (0)6 76 12 67 73/+3902438114218
e-mail: martine.konorski@sorin.com
    

Carla Vidra
Investor Relations
Sorin Group
Tel: +39 02 69969716
e-mail: carla.vidra@sorin.com

Press Office
Image Building
Simona Raffaelli
Tel. + 39 02 89011300
e-mail: sorin@imagebuilding.it
 

.pdf